Deep Medicine Acquisition...

NASDAQ: DMAQ · Real-Time Price · USD
2.96
-5.43 (-64.72%)
At close: Jan 31, 2024, 10:00 PM

Deep Medicine Acquisition Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Mar 31, 2023 Mar 31, 2022
Net Income
-8.8M -400.23K -414.05K
Depreciation & Amortization
639.84K n/a n/a
Stock-Based Compensation
n/a n/a n/a
Other Working Capital
n/a n/a n/a
Other Non-Cash Items
n/a -1.82M 4.13K
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
n/a 1.19M -287.96K
Operating Cash Flow
-4M -1.04M -697.87K
Capital Expenditures
-36.34K n/a n/a
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
2.48M n/a n/a
Other Investing Acitivies
-1.7M 120.42M -127.77M
Investing Cash Flow
741.14K 120.42M -127.77M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a -121.03M n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
8.74M -119.67M 128.84M
Financial Cash Flow
8.74M -119.67M 128.84M
Net Cash Flow
5.48M -281.56K 377.03K
Free Cash Flow
-4.03M -1.04M -697.87K